Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder

Active, not recruitingOBSERVATIONAL
Enrollment

112

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

January 20, 2027

Study Completion Date

January 20, 2027

Conditions
Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
Interventions
OTHER

No intervention; observational

No intervention; observational

Trial Locations (23)

10016

New York University, New York

14050

DRK Berlin - Epilepsiezentrum und Neuropädiatrie, Berlin

19104

Childrens Hospital of Philadlephia Division of Neurology, Philadelphia

28009

Hospital Infantil Universitario Niño Jesús, Madrid

28034

Ruber Internacional Hospital, Madrid

30093

Center for Rare Neurological Diseases, Norcross

37126

Azienda Ospedaliera Universitaria Integrata di Verona, Verona

44195

The Cleveland Clinic, Cleveland

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

50139

Azienda Ospedaliero-Universitaria Meyer, Florence

75015

Hopital Necker- Enfants Malades, Paris

77030

Baylor College of Medicine, Houston

80045

Children's Hospital Colorado, Aurora

83569

Schön Klinik Vogtareuth, Vogtareuth

90095

UCLA Mattel Children's Hospital, Los Angeles

02115

Boston Children's Hospital, Boston

T3B 6A8

Alberta Children's Hospital, Pediatric Epilepsy and Child Neurology, Calgary

Unknown

The Hospital of Sick Children, Toronto

Ospedale Pediatrico Bambino Gesù, Rome

Hospital UniversitarioVithas Madrid, Madrid

Ruber Internacional Hospital, Madrid

Mediclinic, Dubai

00168

Fondazione Policlinico Universitario A Gemelli, IRCCS, Roma

All Listed Sponsors
lead

Loulou Foundation

OTHER